Systemic Molecularly Targeted Therapies for Neoadjuvant and Salvage Craniopharyngioma: A Contemporary Narrative Review

Craniopharyngiomas are rare, histologically benign but locally aggressive intracranial tumors that are associated with substantial visual, endocrine, and hypothalamic morbidity. Advances in molecular characterization have enabled the use of systemic molecularly targeted therapies, particularly in th...

Descripció completa

Dades bibliogràfiques

Autors principals:	Joseph J. Neubecker, Daniel W. Griepp, Jeffrey P. Turnbull, Joshua Caskey, Shivum Desai, Adam Mansour, Rabia Ahmed, Andrew Beggs, Annie T. K. Griepp, Heather Heitkotter, Chad F. Claus, Boyd F. Richards, Prashant S. Kelkar
Format:	Artigo
Idioma:	Inglês
Publicat:	MDPI AG 2026-02-01
Col·lecció:	Biomedicines
Matèries:	papillary craniopharyngioma adamantinomatous craniopharyngioma <i>BRAF V600E</i> MEK inhibitor IL-6/IL-6 receptor blockade bevacizumab
Accés en línia:	https://www.mdpi.com/2227-9059/14/3/499
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!